REPLICor Incorporated Company Profile

17:45 EDT 20th March 2018 | BioPortfolio

REPLICor is focused on discovering and developing a technology based upon the biological mechanisms of the initiation of DNA replication. Notwithstanding its focus, the company has access to a broadly applicable technology for the fields of gene therapy vectors, novel therapeutics and drug discovery tools. The company is currently working in three programs: i) Gene Therapy involving a platform technology based on the origin of DNA replication consensus sequence for gene therapy vectors; ii) Modulation of Cell Division for the development of target proteins and lead compounds targeting DNA replication for cancer and tissue regeneration; and iii) Screening & Designing concerning an enabling drug discovery methodology for discovery of new drugs for cancer and tissue regeneration.


1550 Metcalfe, Suite 502
H3A 1X6


Phone: 514 842 9849
Fax: 514 842 1505

News Articles [2 Associated News Articles listed on BioPortfolio]

Replicor HBV combo leads to functional control

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [39 Associated Companies listed on BioPortfolio]

Replicor Inc.

Replicor is a privately held biopharmaceutical company with the most advanced animal and human clinical data in the development of the cure for HBV and HDV. The company is dedicat...


REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV,...

REPLICor Incorporated

REPLICor is focused on discovering and developing a technology based upon the biological mechanisms of the initiation of DNA replication. Notwithstanding its focus, the company has access to a broadly...


PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...


Founded in 2008 by the Axis Biotec Brasil™ group (, PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "REPLICor Incorporated" on BioPortfolio

We have published hundreds of REPLICor Incorporated news stories on BioPortfolio along with dozens of REPLICor Incorporated Clinical Trials and PubMed Articles about REPLICor Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of REPLICor Incorporated Companies in our database. You can also find out about relevant REPLICor Incorporated Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Corporate Database Quicklinks

Searches Linking to this Company Record